Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease
Bruce E. Sands, Laurent Peyrin‐Biroulet, Jarosław Kierkuś, Peter Higgins, Monika Fischer, Vipul Jairath, Fumihito Hirai, Geert D’Haens, Ruth M. Belin, Debra L. Miller, Elisa Gomez‐Valderas, April N. Naegeli, Jay Tuttle, Paul F. Pollack, William J. Sandborn
Topics & Concepts
MedicineGastroenterologyInternal medicineConfidence intervalPlaceboRandomized controlled trialCohortCrohn's diseaseClinical endpointAdverse effectSurgeryDiseasePathologyAlternative medicineInflammatory Bowel DiseasePsoriasis: Treatment and PathogenesisSpondyloarthritis Studies and Treatments